Recently, pharmaceutical companies have been pricing many of their products at astounding values. A couple years ago, in fact, an amazing new hepatitis C drug came to market priced at about $90,000 per patient. But since that time, several other … Continue reading →
Author Archive: Peter Ubel
Research led by Stacey McMorrow (a former student of mine) shows that Obamacare was especially helpful in enabling black and Hispanic people obtain healthcare insurance: Disparities in insurance rates among either groups are declining:
The post Obamacare Reduced Racial Disparities in Healthcare Insurance appeared first on PeterUbel.com.
In a healthy consumer market, people compare the price and quality of goods inside whether it’s worth paying extra money to get the best possible products. In healthcare, it’s often almost impossible to figure out what things cost. And when … Continue reading →
The post Need More Evidence the U.S. Healthcare Market Is Screwed Up? appeared first on PeterUbel.com.
Here is a figure reproduced in Fortune, showing that when researchers publish articles raising questions about the harms of salt, they cite other researchers who raised similar questions. By contrast, when they definitively argue in favor of the harms, they … Continue reading →
Prince died of an opioid overdose. A tragic and avoidable fate but, even more tragically, one that is becoming increasingly common in the United States. Some people who overdose live on the edge of society – homeless and with no access to … Continue reading →
The post Would Prince Be Alive Today If He’d Had a Different Doctor? appeared first on PeterUbel.com.
I sometimes worry that my wife Paula won’t be able to see me grow old. Not that I expect to outlive her. She is four years my junior and has the blood pressure of a 17-year-old track star. It’s her … Continue reading →
The post An Easy (But Politically Complicated) Way To Save Billions Of Dollars On Medical Care appeared first on PeterUbel.com.
There have been many wonderful new medications in the past decade or so, drugs that finally bring hope for many people with serious illnesses like rheumatoid arthritis, multiple sclerosis and even some advanced cancers. But these drugs often come at … Continue reading →
Very interesting article in the Lancet recently, from the nudge unit in the United Kingdom. They give physicians feedback on how much they prescribed antibiotics compared to their peers, and found that such feedback reduced antibiotic prescriptions. I hope to … Continue reading →
Here is a report from a study I collaborated on, led by the amazing Reshma Jagsi, a physician at the University of Michigan. It reveals just how common it is for female academic physicians to report experiencing sexual harassment in … Continue reading →